We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New molecular entities.
- Abstract
The article presents information on the recently developed drugs by various pharmaceutical companies in the United States. Theses drugs are approved by the U.S. Food and Drug Administration (FDA) for their therapeutic use. Sepracor Inc. has developed Brovana in the group of arformoterol. Brovana is useful in the treatment of chronic obstructive pulmonary disease. Merck & Co. Inc. has introduced Zolinza in the group of vorinostat. It is approved for the treatment of T-cell lymphoma.
- Subjects
UNITED States; DRUG development; DRUG approval; UNITED States. Food &; Drug Administration; SEPRACOR Inc.; MERCK &; Co. Inc.; PHARMACEUTICAL industry
- Publication
Formulary, 2006, Vol 41, Issue 11, p555
- ISSN
1082-801X
- Publication type
Article